Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Categories
Health Care
Anthem, Inc. (ANTM) Q4 2021 Earnings Call Transcript
Anthem, Inc. (NYSE: ANTM) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Stephen Tanal -- Vice President, Investor Relations Gail K. Boudreaux -- President
Johnson & Johnson (JNJ) Q4 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J. Wolk -- Executive
Johnson & Johnson (JNJ) reports Q4 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Royal Philips NV (PHG) Q4 2021 Earnings Call Transcript
Royal Philips NV (AMS: PHG) Q4 2021 earnings call dated Jan. 24, 2022 Corporate Participants: Leandro Mazzoni -- Head of Investor Relations Frans van
Intuitive Surgical Inc. (ISRG) Q4 2021 Earnings Call Transcript
Intuitive Surgical Inc. (NASDAQ: ISRG) Q4 2021 earnings call dated Jan. 20, 2022 Corporate Participants: Brian King -- Head, Investor Relations Gary S. Guthart -- Chief
UnitedHealth Group Incorporated (UNH) Q4 2021 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q4 2021 earnings call dated Jan. 19, 2022 Corporate Participants: Sir Andrew Witty — Chief Executive Officer Dirk McMahon — President
Key highlights from UnitedHealth Group’s (UNH) Q4 2021 earnings results
UnitedHealth Group (NYSE: UNH) reported fourth quarter 2021 earnings results today. Total revenues were $73.7 billion compared to $65.4 billion in the same
Organigram Holdings, Inc. (OGI) Q1 2022 Earnings Call Transcript
Organigram Holdings, Inc. (NASDAQ: OGI) Q1 2022 earnings call dated Jan. 11, 2022 Corporate Participants: Beena Goldenberg -- Chief Executive Officer Derrick West -- Chief Financial
Tilray, inc (TLRY) Q2 2022 Earnings Call Transcript
Tilray, inc (NASDAQ: TLRY) Q2 2022 earnings call dated Jan. 10, 2022 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin D. Simon -- Chairman
Bristol-Myers bets on product pipeline to beat patent issues. Is BMY a buy?
The pharma sector has been on a stable growth trajectory lately, and the trend gathered momentum when the pandemic-related emergency made companies
Infographic: How Tilray (TLRY) performed in Q2 2022
Tilray (NASDAQ: TLRY) reported second-quarter 2022 financial results before the regular market hours on Monday. Total net revenue increased 20% year-over-year to
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
Credit:DavidBGray on iStock Tell us a bit about your clinical programs and how they are different from the existing therapies. Addex is
Walgreens Boots Alliance Inc. (WBA) Q1 2022 Earnings Call Transcript
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q1 2022 earnings call dated Jan. 06, 2022, Call participants: Tiffany Kanaga -- Vice President of
Angiodynamics Inc (ANGO) Q2 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q2 2022 earnings call dated Jan. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer
Walgreens Boots Alliance (WBA) Q1 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported first quarter 2022 earnings results today. Sales increased 7.8% year-over-year to $33.9 billion. Net earnings
IPO news: Here are a few points to note as Amylyx Pharmaceuticals goes public this week
There are quite a few pharmaceutical companies lined up to make their market debut this week. Among these is Amylyx Pharmaceuticals which
Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering a web-based
IPO news: What to look for when Vigil Neuroscience goes public this week
As the first week of the new year slowly unfolds, it appears the pharmaceutical industry is taking the front seat in the
Here are 2 top stock picks to enrich your portfolio in the new year
For businesses across the world, 2021 was a special year for many reasons -- a period of great uncertainty due to the
IPO Alert: Key facts about CinCor Pharma’s upcoming market debut
The healthcare sector, led by pharmaceutical and biotechnology firms, has contributed significantly to the IPO boom that sent the market into overdrive